This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Shatavari work to balance hormones in women?
Shatavari contains steroidal saponins called shatavarins I-IV, along with isoflavones that exhibit phytoestrogenic activity. These compounds bind to estrogen receptors and may help modulate hormonal signaling pathways throughout the female reproductive system. As an adaptogen, Shatavari also supports the hypothalamic-pituitary-adrenal axis, helping the body manage stress, which indirectly influences reproductive hormone balance. Traditional Ayurvedic use spans centuries for female reproductive health, though modern clinical evidence remains limited (Evidence Level B).
Does Shatavari interact with any medications or hormone treatments?
Shatavari may interact with hormone therapies due to its phytoestrogenic properties. Individuals taking estrogen-based medications, birth control pills, or hormone replacement therapy should use Shatavari cautiously, as it may potentiate estrogenic effects. Those with estrogen-sensitive conditions such as breast cancer, endometriosis, or uterine fibroids should avoid Shatavari or consult a healthcare provider before use. No major drug interactions have been well-documented in clinical literature, but evidence remains limited (Evidence Level B).
What is the recommended dosage for Shatavari powder or extract?
The typical adult dosage for Shatavari is 3-6 grams of powdered root daily, or 500 mg of standardized extract taken twice daily. Powder can be mixed with warm milk or water for traditional consumption. Standardized extracts typically contain specified amounts of shatavarins for consistent potency. Dosage may vary based on formulation and intended use. Always follow product label instructions or consult a qualified herbalist or healthcare provider for personalized dosing recommendations.
Is Shatavari safe to take during pregnancy and breastfeeding?
Shatavari is traditionally considered safe during pregnancy and breastfeeding in Ayurvedic practice and is classified as safe for these populations. It has been used for centuries to support healthy lactation and female reproductive health. However, pregnant and breastfeeding women should consult a healthcare provider before starting any herbal supplement. Those with fever or acute illness should avoid Shatavari, as traditional contraindications suggest it may exacerbate certain acute conditions.
Does Shatavari really increase breast milk supply?
Shatavari is widely used as a galactagogue to support and increase breast milk production. Traditional Ayurvedic texts describe it as a premier herb for enhancing lactation, and it remains one of the most commonly recommended herbs for breastfeeding mothers in Ayurvedic practice. Evidence supporting its galactagogue effects is limited but promising (Evidence Level B), with some small observational studies suggesting improved milk production. Women experiencing low milk supply should consult a lactation consultant or healthcare provider for comprehensive support.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Shatavari (Asparagus racemosus) is an Ayurvedic herb traditionally used to support female reproductive health and lactation [PMID:30000872, PMID:41055223].
Background
Asparagus racemosus, known as Shatavari, is a medicinal plant found in tropical and subtropical India and is distinct from the edible Asparagus officinalis [PMID:30000872, PMID:17240097]. It is described in Ayurveda as a rasayana herb and adaptogen used to increase non-specific resistance to stress [PMID:17240097].
Traditional uses
Traditionally used in Ayurveda for female reproductive health, as a galactogogue to increase breast milk, and for the treatment of gastric ulcers, dyspepsia, nervous disorders, inflammation, liver diseases, and certain infectious diseases [PMID:30000872, PMID:14515032, PMID:38725785].
Active compounds
The root contains steroidal saponins (specifically shatavarins I-VI), phytoestrogens, flavonoids, polyphenols, polysaccharides, mucilage, folic acid, sarsasapogenin, and alkaloids [PMID:30000872, PMID:40334116].
Mechanism of action
Shatavari exhibits adaptogenic, anti-inflammatory, and antioxidant properties [PMID:40334116, PMID:40454371]. It may target estrogen receptor alpha and show antiproliferative activity in T47D cancer cell lines [PMID:30580607]. In neuroprotection, it may lower oxidative stress, regulate neuroinflammation, and prevent amyloid-beta development [PMID:40454371].
Clinical evidence
Evidence BPostpartum Lactation
Controlled studies indicate increased serum prolactin, infant weight, greater milk volumes, and shorter times to breast fullness at 72 hours postpartum compared to placebo [PMID:30000872].
Evidence BMenopausal/Perimenopausal Symptoms
Standardized root extract has been evaluated for reducing vasomotor symptoms, improving hormonal balance, and decreasing Menopause Rating Scale (MRS) scores [PMID:40434025, PMID:41209045, PMID:41394012].
Evidence BPostmenopausal Muscle Function
Six weeks of supplementation improved handgrip strength and increased markers of myosin contractile function [PMID:38214710].
Evidence BPostmenopausal Vascular and Bone Health
Dose-dependent decrease in Menopause-Specific Quality of Life (MENQOL) scores and reflection index (RI) was observed [PMID:40347163].
Safety & adverse effects
Shatavari is generally described as having no significant adverse effects in clinical and preclinical settings [PMID:33689806].
Pregnancy & lactation
Traditionally used as a galactogogue [PMID:30000872]; however, pregnant and breastfeeding women are advised to consult healthcare professionals before use [PMID:40974515].
Dosage & administration
Clinical trials have utilized various dosages, including 200 mg/day [PMID:40434025], 300 mg twice daily [PMID:41055223], and 300 mg once daily [PMID:41209045]. No PubMed data available. Consult a healthcare provider.
Evidence summary
The evidence is primarily based on randomized controlled trials (Level B) and reviews (Level C), showing promise for lactation and menopausal symptom management, though some results for galactogogue activity are mixed [PMID:30000872].
PubMed sources
1.PMID: 30000872 (2006) — Ayurvedic Herbal Medicines: A Literature Review of Their Applications in Female Reproductive Health. · Cureus
2.PMID: 38725785 (2024) — Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial. · Cureus
3.PMID: 14515032 (2003) — Asparagus racemosus--an update. · Indian journal of medical sciences
4.PMID: 41055223 (2025) — Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study. · Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
5.PMID: 40434025 (2025) — A Standardized Asparagus Racemosus Root Extract Improves Hormonal Balance and Menstrual Health and Reduces Vasomotor Symptoms in Perimenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 41209045 (2025) — Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: Randomized, Double-Blind, Placebo-Controlled Study. · International journal of women's health
7.PMID: 38214710 (2024) — Shatavari supplementation in postmenopausal women alters the skeletal muscle proteome and pathways involved in training adaptation. · European journal of nutrition
8.PMID: 40334116 (2025) — An Updated Insight on the Chemistry, Ethnobotany, and Health Benefits of Asparagus racemosus (Shatavari): With a Special Emphasis on Shatavarin IV. · Journal of the American Nutrition Association
9.PMID: 40454371 (2025) — Exploring the neuroprotective role of Asparagus racemosus (Shatavari) in Alzheimer's disease: mechanisms, evidence, and future directions. · 3 Biotech
10.PMID: 41394012 (2025) — Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. · Frontiers in reproductive health
11.PMID: 30580607 (2020) — Asparagus racemosus (Shatavari) targeting estrogen receptor α: - An in-vitro and in-silico mechanistic study. · Natural product research
12.PMID: 40974515 (2025) — Shatavari (Asparagus racemosus): A Promising Ally for Fertility. · Current nutrition reports
13.PMID: 29635127 (2018) — Impact of stress on female reproductive health disorders: Possible beneficial effects of shatavari (Asparagus racemosus). · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
14.PMID: 33689806 (2021) — Neuro-nutraceutical potential of Asparagus racemosus: A review. · Neurochemistry international
15.PMID: 36433663 (2023) — Asparagus (Asparagus racemosus L.) roots: nutritional profile, medicinal profile, preservation, and value addition. · Journal of the science of food and agriculture
16.PMID: 17240097 (2007) — Asparagus racemosus--ethnopharmacological evaluation and conservation needs. · Journal of ethnopharmacology
17.PMID: 26463825 (2016) — Asparagus racemosus: a review on its phytochemical and therapeutic potential. · Natural product research
18.PMID: 40347163 (2025) — Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study. · Journal of menopausal medicine